- The key active ingredients in the Boswellia Serrata extract are the Boswellia acids (BA). Of the various acids, the acetyl group of BA are the most potent anti-inflammatory agents. And the most active acetyl BA is acetyl ketoboswellic acid (AKBA). Studies have proved that AKBA has the unique ability to inhibit the biomolecules responsible for bronchial muscle contraction and mucous secretion respectively (5LOX or 5 lipoxygenase and HLE or human leukocyte elastase).
- HLE (human leukocyte elastase) stimulates mucus secretion and also plays a role in cystic fibrosis, chronic bronchitis, and acute respiratory distress syndrome besides injuring the tissues and triggering the inflammatory process. Breathe Sure is standardised with acetyl group of BA with 10% AKBA.
- Fights Respiratory Disorders & Infections, Improves Overall Lung Health
- Reduces Coughing & Wheezing, Regulates Chest Tightness & Breathlessness
- ISO 22000:2018, GMP certified manufacturer
DAILY BOSWELLIA
₹675.00 / month
Boswellia extract rich in AKBA to support clear breathing and reduce inflammation.
| Ingredients | Boswellia Serrata Extract |
|---|---|
| Size | 30 Capsules, 60 Capsules |
Know More About DAILY BOSWELLIA
How does Boswellia extract work to manage respiratory problems?
The key active ingredients in the Boswellia Serrata extract are the Boswellia acids (BA). Of the various acids, the acetyl group of BA are the most potent anti-inflammatory agents. And the most active acetyl BA is acetyl ketoboswellic acid (AKBA).
Studies have proved that AKBA has the unique ability to inhibit the biomolecules responsible for bronchial muscle contraction and mucous secretion respectively (5LOX or 5 lipoxygenase and HLE or human leukocyte elastase). HLE (human leukocyte elastase) helps stimulate mucus secretion and also plays a role in cystic fibrosis, chronic bronchitis, and acute respiratory distress syndrome besides injuring the tissues and triggering the inflammatory process.
Daily Boswellia is standardised with acetyl group of BA with 10% AKBA.
What are the common indications that can be managed with Boswellia extract?
⢠Osteoarthritis (OA)
⢠Rheumatoid arthritis (RA)
⢠Asthma
⢠Inflammatory bowel disease
What are NSAIDs and why is the combination of Boswellia and curcumin extract superior to it?
NSAIDs are non-steroid anti-inflammatory drugs, a common drug type used in the treatment of knee pain (osteoarthritis). In some cases, NSAIDs may affect gastrointestinal, renal and cardiovascular systems. Boswillia and curcumin combination is highly effective in managing osteoarthritis. Various studies have shown that it does not affect any other physiological systems.
What is the recommended dose of Daily Boswellia?
We recommend taking 1-2 capsule in the morning and 1 at night everyday after having your food.
Can I get Daily Boswellia delivered to me automatically every month?
Yes. All you have to do is subscribe and weāll ship you a bottle every month!
Can I gift Daily Boswellia to my friends or family directly?
Yes, just select the gifting option and weāll send it to them with a special note from you!
Other Frequently Asked Questions
Does it cause any side effects?
Daily Boswellia does not typically cause any side effects.
Please consult your healthcare practitioner before using the supplement if you are pregnant, taking any medications or facing any health conditions.
When should I expect to see results?
Every individual is different so the speed of results may vary. But you can usually see results after 3-6 weeks if you take the recommended dose regularly.
Is the Boswellia and curcumin combination available easily in the market?
It is not available over the counter. Orders can be made through our website.
What should I do if I miss a dose?
Donāt worry, just take the dose when you realise youāve missed it! However, if the time is close to your next dose, then continue with your usual regimen.
What other directions should I follow?
⢠Store in a cool and dry place.
⢠Keep out of reach of children.
⢠Do not exceed daily recommended dose.









Reviews
There are no reviews yet.